Thursday, May 30, 2024
HomeHealth ConditionsDiabetesNew microneedle pill may replace insulin injections

New microneedle pill may replace insulin injections

Researchers from The Massachusetts Institute of Technology developed a new microneedle pill that can deliver insulin through the stomach, potentially replacing injections for patients with diabetes.

Diabetes is one of the most common and costly chronic diseases. It is the third-leading cause of death in the United States. According to the leading national public health institute of the U.S., The Centers for Disease Control and Prevention, there are more than 100 million U.S. adults are now living with diabetes or prediabetes. The chance of getting diabetes is higher if an individual is overweight, obesity, inactive, or have a family history of diabetes.

Type 2 diabetes is the most common form of diabetes. In type 2 diabetes, the body does not use insulin properly, also known as insulin resistance. Many people with diabetes are prescribed insulin, which is a naturally occurring hormone secreted by the pancreas. However, insulin cannot be taken as a pill because acids in the stomach would destroy it before it can enter into the bloodstream. Some people also find particular insulins can hurt to inject or lead to an allergic reaction at the injection site.

New microneedle pill could deliver oral doses of insulin

In a recent study published in the world’s top scientific journal, Science, a research team led by The Massachusetts Institute of Technology developed a new microneedle pill that can deliver oral formulations of insulin through the stomach.

Inspired by the self-orienting leopard tortoise, the pill contains a small biodegradable needle made of compressed freeze-dried insulin, which is capable of resisting external forces upon reaching a stable point by rapid self-orientation. When the pill is swallowed, liquid in the stomach dissolves the sugar casing, triggering the injection of the needle into the stomach wall.

New treatment works well in animals

In tests in animals, the researchers showed that they could deliver up to 0.5 mg of insulin, which is comparable to the amount that a patient with type 2 diabetes would need to inject through the skin. After the pill releases its contents, it can harmlessly pass through the digestive system.

This groundbreaking research not only finds applications in insulin oral delivery, but also benefits to many other protein drugs that normally have to be injected. More studies are required to determine the chronic effects of daily gastric injections.

Written by Man-tik Choy, Ph.D

References:

  1. Abramson, A. et al. An ingestible self-orienting system for oral delivery of macromolecules. Science, 2019;363(6427):611-615. DOI: 10.1126/science.aau2277.
  2. Photo credit: Felice Frankel https://www.eurekalert.org/multimedia/pub/191899.php?from=419488
Man-tik Choy PhD
Man-tik Choy PhD
Man-Tik has a Ph.D. in Material Science and Engineering from the Hong Kong Polytechnic University. His research focuses on pharmaceutical sciences, biomaterial design and development, and advanced manufacturing technologies. Man-Tik has developed a strong interest in knowledge discovery and sharing through his practical training in different joint research projects. He is excited to contribute to Medical News Bulletin and help the public to understand science more effectively. In his free time, Man-Tik enjoys reading novels and painting.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

Recognizing HIE: A Call for Advocacy

Have you heard of HIE? It’s the second leading cause of infant mortality and lifelong disability worldwide. 2-3 per 1,000 live births in high-income...

Joke Of The Day – May 30

Patient: Doc, please come to my home as soon as possible! My wife has appendicitis! Doctor: Don't worry. Two years ago I did surgery to...

ADVERTISE WITH US

error: Content is read-only and copy-protected.